These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 18357379)
41. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma. Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617 [TBL] [Abstract][Full Text] [Related]
42. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
43. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399 [TBL] [Abstract][Full Text] [Related]
45. Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining. Kharfan-Dabaja MA; Patel SA; Osunkoya AO; Kojouri K; Kamble R; Yang J; Hashmi M; Ozer H; Selby GB Clin Lab Haematol; 2006 Aug; 28(4):254-8. PubMed ID: 16898965 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Raica M; Mogoantă L; Cîmpean AM; Alexa A; Ioanovici S; Mărgăritescu C; Lazăr D; Izvernariu D Rom J Morphol Embryol; 2008; 49(1):37-42. PubMed ID: 18273500 [TBL] [Abstract][Full Text] [Related]
47. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848 [TBL] [Abstract][Full Text] [Related]
48. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma. Han FH; Li HM; Zheng DH; He YL; Zhan WH Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167 [TBL] [Abstract][Full Text] [Related]
49. Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma. Choi JH; Oh YH; Park YW; Baik HK; Lee YY; Kim IS J Korean Med Sci; 2008 Aug; 23(4):592-7. PubMed ID: 18756043 [TBL] [Abstract][Full Text] [Related]
50. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225 [TBL] [Abstract][Full Text] [Related]
51. High expression of HER3 is associated with a decreased survival in gastric cancer. Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113 [TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma. Baek SK; Jung KY; Lee SH; Woo JS; Kwon SY; Chung EJ; Kim TH; Chae YS Laryngoscope; 2009 Jul; 119(7):1325-30. PubMed ID: 19444880 [TBL] [Abstract][Full Text] [Related]
53. Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage. Schmidt M; Voelker HU; Kapp M; Dietl J; Kammerer U Anticancer Res; 2008; 28(3A):1719-24. PubMed ID: 18630531 [TBL] [Abstract][Full Text] [Related]
54. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Chatterjee D; Sabo E; Tavares R; Resnick MB Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365 [TBL] [Abstract][Full Text] [Related]
55. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447 [TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma. Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346 [TBL] [Abstract][Full Text] [Related]
57. Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. Matsubara J; Yamada Y; Nakajima TE; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T Oncology; 2008; 74(1-2):76-83. PubMed ID: 18544998 [TBL] [Abstract][Full Text] [Related]
58. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Brychtova S; Bezdekova M; Brychta T; Tichy M Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336 [TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis. Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232 [TBL] [Abstract][Full Text] [Related]
60. [Gastric carcinoma: a histopathological study of 705 cases]. Leocata P; Ventura L; Giunta M; Guadagni S; Fortunato C; Discepoli S; Ventura T Ann Ital Chir; 1998; 69(3):331-7. PubMed ID: 9835105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]